Skip to main content

Moringa oleifera: A Powerful Source of Environmentally, Medicinally and Biotechnologically Relevant Compounds | Chapter 06 | Advances in Applied Science and Technology Vol. 5

Moringa oleifera Lamarck (Moringaceae family) is a plant native from the Western and sub-Himalayan parts of Northwest India, Pakistan and Afghanistan. This species is widely cultivated across Africa, South-East  Asia,  Arabia,  South  America  and  Caribbean  Islands. M.  oleifera culture  is  also  being distributed  in  the  Semi-Arid  Northeast  of  Brazil.  It  is  a  multiuse  life  tree  with  great  environmental economic  importance in  industrial and medical areas. This review reports  different purposes of M. oleifera including  sustaining  environmental  resources,  soil  protection  and  shelter  for  animals.  This plant requires not much care and distinct parts have bioactive compounds. Moringa tissues used in human and animal diets, also withdraw pollutants from water. The seeds with coagulant properties used  in  water  treatment  for  human  consumption,  remove  waste  products  like  surfactants,  heavy metals and pesticides. The oil extracted from seeds is used in cosmetic production and as biodiesel. M.  oleifera tissues  also  contain  proteins  with  different  biological  activities,  including  lectins,  chitin-binding  proteins,  trypsin  inhibitors,  and  proteases.  The  lectins  are  reported  to  act  as  insecticidal agents  against Aedes  aegypti (vector  of  dengue,  chikungunya  and  yellow  fevers)  and Anagasta kuehniella (pest  of  stored products) and  also  showed  water  coagulant,  antibacterial,  antineoplastic and blood anticoagulant activities. The presence of trypsin inhibitors has been reported in M. oleifera leaves and flowers. The inhibitor from flowers is toxic to larvae of A.  aegypti and to the protozoan Trypanosoma cruzi. The flowers also contain caseinolytic proteases that are able to promote clotting of milk. In this sense, M. oleifera is a promising tree from a biotechnological point of view, since it has shown a great variety of uses and it is a source of several compounds with a broad range of biological activities.

Author(s) Details

Thiago Henrique Napoleão
Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Avenida Prof. Moraes Rego, S/N, Cidade Universitária, Recife-PE, 50670-420, Brazil.

Andréa F. S. Santos
CEB -Centre of Biological Engineering, University of Minho, Braga, 4710-057, Portugal.

Luciana de Andrade Luz
Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo-SP, 04044-020, Brazil.

Emmanuel Viana Pontual
Departamento de Morfologia e Fisiologia Animal, Universidade Federal Rural de Pernambuco, Recife-PE, 52171-900, Brazil.

Patrícia M. G. Paiva
Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Avenida Prof. Moraes Rego, S/N, Cidade Universitária, Recife-PE, 50670-420, Brazil.

Luana C. B. B. Coelho
Departamento de Bioquímica, Centro de Biociências, Universidade Federal de Pernambuco, Avenida Prof. Moraes Rego, S/N, Cidade Universitária, Recife-PE, 50670-420, Brazil.

Read full article: http://bp.bookpi.org/index.php/bpi/catalog/view/44/198/350-1
View Volume: https://doi.org/10.9734/bpi/aast/v5
Labels:

Comments

Post a Comment

Popular posts from this blog

A Prospective Study about Safety and Efficacy of Perioperative Lidocaine Infusion | Chapter 09 | New Horizons in Medicine and Medical Research Vol. 8

 Opioids cause clinically significant side effects such as respiratory depression, immunosuppression, muscle rigidity, negative inotropism, nausea, vomiting, hyperalgesia, urine retention, postoperative ileus, and drowsiness. Perioperative opioids are a major contributor to the United States' and other countries' opioid epidemics. Non-opioid analgesics, particularly lidocaine, are becoming more common for perioperative use as a result of this. A total of 185 adult patients were randomly assigned to one of two groups: control group I (105 patients) [fentanyl group] or group ii (80 patients) [opioid-free anaesthesia group]. Lidocaine 1.5 mg/kg bolus followed by 1.5 mg/kg/h infusion intraoperatively, and 1.5-2 mg/kg/h infusion for 2-8 hours postoperatively were given to patients in both groups at anaesthetic induction. Intraoperatively, both groups received analgesic adjuvants such as diclofenac 75 mg, paracetamol 1 gm, and mgso4 30-50 mg/kg. If the mean arterial pressure (map)
Post a Comment
Read more

A Brief Study of Middleware Technologies: Programming Applications and Management Systems | Chapter 15 | Novel Research Aspects in Mathematical and Computer Science Vol. 1

  Many platforms, services, applications, hardware, and operating systems are connected through the middleware layer. Because the middleware layer abstracts much low-level complexity and makes applications and software systems portable, it allows disparate systems to interface and function together in harmony. Middleware technologies enable software engineers to swiftly construct software systems and applications, allowing developers to focus on more important tasks. This chapter examines several types of middleware systems and discusses middleware capabilities, middleware operation, middleware's function in cloud-based systems, and the best middleware platforms to use. Middleware systems are widely utilised and can be found in practically any software system or application. Middleware programmes provide as a link between many sorts of systems and protocols. They serve as a mechanism for various systems. To successfully exchange information, it runs on a variety of operating system
Post a Comment
Read more

Patients’ Perspective of Acute Post-operative Pain Management: A Multicentre Survey of Tertiary Hospitals in Maharashtra, India | Chapter 08 | New Horizons in Medicine and Medical Research Vol. 8

 When postoperative pain is adequately controlled, patients' satisfaction and patient-related outcomes (PROs) increase. Understanding the patients' perspective is crucial since it supports in the formulation of improvement strategies. Because wrong attitudes and assumptions might block pain alleviation, patients' attitudes and beliefs are critical. As a result, a multicenter study of patients' attitudes, beliefs, experiences, and satisfaction levels with acute postoperative pain management was done in Maharashtra's tertiary hospitals. In addition, the responses were examined to evaluate if the Acute Pain Service (APS) resulted in improved patient outcomes and satisfaction. A 13-item questionnaire adapted from previous studies was used to capture patients' experiences with postoperative pain treatment. The responses of 179 patients are included in the study. The findings revealed that 91.6 percent of patients experienced postoperative pain, with 75.5 percent
Post a Comment
Read more